Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 215 entries
Sorted by: Best Match Show Resources per page
From methods to policy: the intended and unintended consequences of comparative effectiveness research.

Journal of comparative effectiveness research

Dubois RW.
PMID: 24237293
J Comp Eff Res. 2012 Jan;1(1):13-4. doi: 10.2217/cer.11.9.

No abstract available.

Cite
Dubois RW. From methods to policy: the intended and unintended consequences of comparative effectiveness research. J Comp Eff Res. 2012;1(1):13-4doi: 10.2217/cer.11.9.
Dubois, R. W. (2012). From methods to policy: the intended and unintended consequences of comparative effectiveness research. Journal of comparative effectiveness research, 1(1), 13-4. https://doi.org/10.2217/cer.11.9
Dubois, Robert W. "From methods to policy: the intended and unintended consequences of comparative effectiveness research." Journal of comparative effectiveness research vol. 1,1 (2012): 13-4. doi: https://doi.org/10.2217/cer.11.9
Dubois RW. From methods to policy: the intended and unintended consequences of comparative effectiveness research. J Comp Eff Res. 2012 Jan;1(1):13-4. doi: 10.2217/cer.11.9. PMID: 24237293.
Copy Download .nbib Format: NLM
Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU.

Journal of comparative effectiveness research

Annemans L, Cleemput I, Hulstaert F, Simoens S.
PMID: 24237295
J Comp Eff Res. 2012 Jan;1(1):19-29. doi: 10.2217/cer.11.1.

Over the past 50 years, medicines have made a huge contribution to improving the health status of populations. However, the level of pharmaceutical innovation varies widely, ranging from breakthrough treatments for life-threatening diseases to minor modifications of medicines that...

Cite
Annemans L, Cleemput I, Hulstaert F, et al. Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU. J Comp Eff Res. 2012;1(1):19-29doi: 10.2217/cer.11.1.
Annemans, L., Cleemput, I., Hulstaert, F., & Simoens, S. (2012). Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU. Journal of comparative effectiveness research, 1(1), 19-29. https://doi.org/10.2217/cer.11.1
Annemans, Lieven, et al. "Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU." Journal of comparative effectiveness research vol. 1,1 (2012): 19-29. doi: https://doi.org/10.2217/cer.11.1
Annemans L, Cleemput I, Hulstaert F, Simoens S. Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU. J Comp Eff Res. 2012 Jan;1(1):19-29. doi: 10.2217/cer.11.1. PMID: 24237295.
Copy Download .nbib Format: NLM
Transportability in Network Meta-analysis.

Epidemiology (Cambridge, Mass.)

Kabali C, Ghazipura M.
PMID: 26963292
Epidemiology. 2016 Jul;27(4):556-61. doi: 10.1097/EDE.0000000000000475.

Network meta-analysis is an extension of the conventional pair wise meta-analysis to include treatments that have not been compared head to head. It has in recent years caught the interest of clinical investigators in comparative effectiveness research. While allowing...

Cite
Kabali C, Ghazipura M. Transportability in Network Meta-analysis. Epidemiology. 2016;27(4):556-61doi: 10.1097/EDE.0000000000000475.
Kabali, C., & Ghazipura, M. (2016). Transportability in Network Meta-analysis. Epidemiology (Cambridge, Mass.), 27(4), 556-61. https://doi.org/10.1097/EDE.0000000000000475
Kabali, Conrad, and Ghazipura, Marya. "Transportability in Network Meta-analysis." Epidemiology (Cambridge, Mass.) vol. 27,4 (2016): 556-61. doi: https://doi.org/10.1097/EDE.0000000000000475
Kabali C, Ghazipura M. Transportability in Network Meta-analysis. Epidemiology. 2016 Jul;27(4):556-61. doi: 10.1097/EDE.0000000000000475. PMID: 26963292.
Copy Download .nbib Format: NLM
Comparative effectiveness medicines research cannot assess efficacy.

Journal of clinical epidemiology

Dal-Ré R, Carcas AJ.
PMID: 28919461
J Clin Epidemiol. 2017 Dec;92:129. doi: 10.1016/j.jclinepi.2017.09.008. Epub 2017 Sep 14.

No abstract available.

Cite
Dal-Ré R, Carcas AJ. Comparative effectiveness medicines research cannot assess efficacy. J Clin Epidemiol. 2017;92:129doi: 10.1016/j.jclinepi.2017.09.008.
Dal-Ré, R., & Carcas, A. J. (2017). Comparative effectiveness medicines research cannot assess efficacy. Journal of clinical epidemiology, 92129. https://doi.org/10.1016/j.jclinepi.2017.09.008
Dal-Ré, Rafael, and Carcas, Antonio J. "Comparative effectiveness medicines research cannot assess efficacy." Journal of clinical epidemiology vol. 92 (2017): 129. doi: https://doi.org/10.1016/j.jclinepi.2017.09.008
Dal-Ré R, Carcas AJ. Comparative effectiveness medicines research cannot assess efficacy. J Clin Epidemiol. 2017 Dec;92:129. doi: 10.1016/j.jclinepi.2017.09.008. Epub 2017 Sep 14. PMID: 28919461.
Copy Download .nbib Format: NLM
Comment on 'heterogeneity in action: the role of passive personalization in comparative effectiveness research'.

Health economics

Epstein D.
PMID: 24435932
Health Econ. 2014 Mar;23(3):374-5. doi: 10.1002/hec.3032. Epub 2014 Jan 16.

No abstract available.

Cite
Epstein D. Comment on 'heterogeneity in action: the role of passive personalization in comparative effectiveness research'. Health Econ. 2014;23(3):374-5doi: 10.1002/hec.3032.
Epstein, D. (2014). Comment on 'heterogeneity in action: the role of passive personalization in comparative effectiveness research'. Health economics, 23(3), 374-5. https://doi.org/10.1002/hec.3032
Epstein, David. "Comment on 'heterogeneity in action: the role of passive personalization in comparative effectiveness research'." Health economics vol. 23,3 (2014): 374-5. doi: https://doi.org/10.1002/hec.3032
Epstein D. Comment on 'heterogeneity in action: the role of passive personalization in comparative effectiveness research'. Health Econ. 2014 Mar;23(3):374-5. doi: 10.1002/hec.3032. Epub 2014 Jan 16. PMID: 24435932.
Copy Download .nbib Format: NLM
European collaboration on relative effectiveness will move into the next phase.

Journal of comparative effectiveness research

Goettsch W.
PMID: 24236514
J Comp Eff Res. 2013 Jan;2(1):5-6. doi: 10.2217/cer.12.70.

No abstract available.

Cite
Goettsch W. European collaboration on relative effectiveness will move into the next phase. J Comp Eff Res. 2013;2(1):5-6doi: 10.2217/cer.12.70.
Goettsch, W. (2013). European collaboration on relative effectiveness will move into the next phase. Journal of comparative effectiveness research, 2(1), 5-6. https://doi.org/10.2217/cer.12.70
Goettsch, Wim. "European collaboration on relative effectiveness will move into the next phase." Journal of comparative effectiveness research vol. 2,1 (2013): 5-6. doi: https://doi.org/10.2217/cer.12.70
Goettsch W. European collaboration on relative effectiveness will move into the next phase. J Comp Eff Res. 2013 Jan;2(1):5-6. doi: 10.2217/cer.12.70. PMID: 24236514.
Copy Download .nbib Format: NLM
Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions.

Journal of comparative effectiveness research

Morrato EH, Concannon TW, Meissner P, Shah ND, Turner BJ.
PMID: 24236560
J Comp Eff Res. 2013 Mar;2(2):185-94. doi: 10.2217/cer.13.10.

AIM: To identify ongoing practices and opportunities for improving national comparative effectiveness research (CER) translation through dissemination and implementation (D&I) via NIH-funded Clinical and Translational Science Award (CTSA) institutions.MATERIALS & METHODS: Key informant interviews were conducted with 18 CTSA...

Cite
Morrato EH, Concannon TW, Meissner P, et al. Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions. J Comp Eff Res. 2013;2(2):185-94doi: 10.2217/cer.13.10.
Morrato, E. H., Concannon, T. W., Meissner, P., Shah, N. D., & Turner, B. J. (2013). Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions. Journal of comparative effectiveness research, 2(2), 185-94. https://doi.org/10.2217/cer.13.10
Morrato, Elaine H, et al. "Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions." Journal of comparative effectiveness research vol. 2,2 (2013): 185-94. doi: https://doi.org/10.2217/cer.13.10
Morrato EH, Concannon TW, Meissner P, Shah ND, Turner BJ. Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions. J Comp Eff Res. 2013 Mar;2(2):185-94. doi: 10.2217/cer.13.10. PMID: 24236560; PMCID: PMC3961460.
Copy Download .nbib Format: NLM
Lessons from comparative effectiveness research methods development projects funded under the Recovery Act.

Journal of comparative effectiveness research

Zurovac J, Esposito D.
PMID: 25494566
J Comp Eff Res. 2014 Nov;3(6):601-7. doi: 10.2217/cer.14.64.

BACKGROUND: The American Recovery and Reinvestment Act of 2009 (ARRA) directed nearly US$29.2 million to comparative effectiveness research (CER) methods development.AIM: To help inform future CER methods investments, we describe the ARRA CER methods projects, identify barriers to this...

Cite
Zurovac J, Esposito D. Lessons from comparative effectiveness research methods development projects funded under the Recovery Act. J Comp Eff Res. 2014;3(6):601-7doi: 10.2217/cer.14.64.
Zurovac, J., & Esposito, D. (2014). Lessons from comparative effectiveness research methods development projects funded under the Recovery Act. Journal of comparative effectiveness research, 3(6), 601-7. https://doi.org/10.2217/cer.14.64
Zurovac, Jelena, and Esposito, Dominick. "Lessons from comparative effectiveness research methods development projects funded under the Recovery Act." Journal of comparative effectiveness research vol. 3,6 (2014): 601-7. doi: https://doi.org/10.2217/cer.14.64
Zurovac J, Esposito D. Lessons from comparative effectiveness research methods development projects funded under the Recovery Act. J Comp Eff Res. 2014 Nov;3(6):601-7. doi: 10.2217/cer.14.64. PMID: 25494566.
Copy Download .nbib Format: NLM
Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis.

Journal of comparative effectiveness research

Zickafoose JS, Kimmey LD, Tomas A, Esposito D, Rich E.
PMID: 25494573
J Comp Eff Res. 2014 Nov;3(6):667-75. doi: 10.2217/cer.14.66.

Multidisciplinary, multi-institutional collaboration has become a key feature of comparative effectiveness research (CER), and CER funders have made promotion of these types of collaboration an implicit, and sometimes explicit, goal of funding. An important challenge in evaluating CER programs...

Cite
Zickafoose JS, Kimmey LD, Tomas A, et al. Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis. J Comp Eff Res. 2014;3(6):667-75doi: 10.2217/cer.14.66.
Zickafoose, J. S., Kimmey, L. D., Tomas, A., Esposito, D., & Rich, E. (2014). Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis. Journal of comparative effectiveness research, 3(6), 667-75. https://doi.org/10.2217/cer.14.66
Zickafoose, Joseph S, et al. "Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis." Journal of comparative effectiveness research vol. 3,6 (2014): 667-75. doi: https://doi.org/10.2217/cer.14.66
Zickafoose JS, Kimmey LD, Tomas A, Esposito D, Rich E. Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis. J Comp Eff Res. 2014 Nov;3(6):667-75. doi: 10.2217/cer.14.66. PMID: 25494573.
Copy Download .nbib Format: NLM
Comparative effectiveness research.

AJNR. American journal of neuroradiology

Hirsch JA, Schaefer PW, Romero JM, Rabinov JD, Sanelli PC, Manchikanti L.
PMID: 24874531
AJNR Am J Neuroradiol. 2014 Sep;35(9):1677-80. doi: 10.3174/ajnr.A3985. Epub 2014 May 29.

The goal of comparative effectiveness research is to improve health care while dealing with the seemingly ever-rising cost. An understanding of comparative effectiveness research as a core topic is important for neuroradiologists. It can be used in a variety...

Cite
Hirsch JA, Schaefer PW, Romero JM, et al. Comparative effectiveness research. AJNR Am J Neuroradiol. 2014;35(9):1677-80doi: 10.3174/ajnr.A3985.
Hirsch, J. A., Schaefer, P. W., Romero, J. M., Rabinov, J. D., Sanelli, P. C., & Manchikanti, L. (2014). Comparative effectiveness research. AJNR. American journal of neuroradiology, 35(9), 1677-80. https://doi.org/10.3174/ajnr.A3985
Hirsch, J A, et al. "Comparative effectiveness research." AJNR. American journal of neuroradiology vol. 35,9 (2014): 1677-80. doi: https://doi.org/10.3174/ajnr.A3985
Hirsch JA, Schaefer PW, Romero JM, Rabinov JD, Sanelli PC, Manchikanti L. Comparative effectiveness research. AJNR Am J Neuroradiol. 2014 Sep;35(9):1677-80. doi: 10.3174/ajnr.A3985. Epub 2014 May 29. PMID: 24874531; PMCID: PMC7966283.
Copy Download .nbib Format: NLM
Comparative effectiveness research stalls in the USA.

Lancet (London, England)

Webster PC.
PMID: 20135825
Lancet. 2010 Jan 30;375(9712):361-2. doi: 10.1016/s0140-6736(10)60150-x.

No abstract available.

Cite
Webster PC. Comparative effectiveness research stalls in the USA. Lancet. 2010;375(9712):361-2doi: 10.1016/s0140-6736(10)60150-x.
Webster, P. C. (2010). Comparative effectiveness research stalls in the USA. Lancet (London, England), 375(9712), 361-2. https://doi.org/10.1016/s0140-6736(10)60150-x
Webster, Paul Christopher. "Comparative effectiveness research stalls in the USA." Lancet (London, England) vol. 375,9712 (2010): 361-2. doi: https://doi.org/10.1016/s0140-6736(10)60150-x
Webster PC. Comparative effectiveness research stalls in the USA. Lancet. 2010 Jan 30;375(9712):361-2. doi: 10.1016/s0140-6736(10)60150-x. PMID: 20135825.
Copy Download .nbib Format: NLM
The policies and politics of creating a comparative clinical effectiveness research center.

Health affairs (Project Hope)

Wilensky GR.
PMID: 19556248
Health Aff (Millwood). 2009 Jul-Aug;28(4):w719-29. doi: 10.1377/hlthaff.28.4.w719. Epub 2009 Jun 25.

As part of the early efforts of the Obama administration to begin health care reform, $1.1 billion for comparative effectiveness research was included in the stimulus bill. Although this amount can be considered as an initial down payment, difficult...

Cite
Wilensky GR. The policies and politics of creating a comparative clinical effectiveness research center. Health Aff (Millwood). 2009;28(4):w719-29doi: 10.1377/hlthaff.28.4.w719.
Wilensky, G. R. (2009). The policies and politics of creating a comparative clinical effectiveness research center. Health affairs (Project Hope), 28(4), w719-29. https://doi.org/10.1377/hlthaff.28.4.w719
Wilensky, Gail R. "The policies and politics of creating a comparative clinical effectiveness research center." Health affairs (Project Hope) vol. 28,4 (2009): w719-29. doi: https://doi.org/10.1377/hlthaff.28.4.w719
Wilensky GR. The policies and politics of creating a comparative clinical effectiveness research center. Health Aff (Millwood). 2009 Jul-Aug;28(4):w719-29. doi: 10.1377/hlthaff.28.4.w719. Epub 2009 Jun 25. PMID: 19556248.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 215 entries